Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer.
Rojo Domingo M, Conlin CC, Karunamuni R, Ollison C, Baxter MT, Kallis K, Do DD, Song Y, Kuperman J, Shabaik AS, Hahn ME, Murphy PM, Rakow-Penner R, Dale AM, Seibert TM.
Rojo Domingo M, et al. Among authors: murphy pm.
Sci Rep. 2024 Dec 28;14(1):31318. doi: 10.1038/s41598-024-82742-8.
Sci Rep. 2024.
PMID: 39732834
Free PMC article.